Literature DB >> 7263816

Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection.

R J Strife, I Jardine, M Colvin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7263816     DOI： 10.1016/s0378-4347(00)80153-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  8 in total

1.  Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.

Authors:  J K Duong; G J Veal; C E Nath; P J Shaw; J Errington; R Ladenstein; A V Boddy
Journal:  Br J Clin Pharmacol       Date:  2018-11-04       Impact factor: 4.335

2.  Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etoposide.

Authors:  H Sato; H Kitazawa; I Adachi; I Horikoshi
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

Review 3.  Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.

Authors:  J J Holthuis
Journal:  Pharm Weekbl Sci       Date:  1988-06-17

4.  Pharmacokinetics of VP16-213 given by different administration methods.

Authors:  M D'Incalci; P Farina; C Sessa; C Mangioni; V Conter; G Masera; M Rocchetti; M B Pisoni; E Piazza; M Beer; F Cavalli
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 5.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

6.  Instability of the anticancer agent etoposide under in vitro culture conditions.

Authors:  R M Mader; G G Steger; K Moser; H Rainer; P Krenmayr; C Dittrich
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Polyester-Based Dendrimer Nanoparticles Combined with Etoposide Have an Improved Cytotoxic and Pro-Oxidant Effect on Human Neuroblastoma Cells.

Authors:  Silvana Alfei; Barbara Marengo; Cinzia Domenicotti
Journal:  Antioxidants (Basel)       Date:  2020-01-06

8.  Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer.

Authors:  R Watanabe; Y Takiguchi; T Moriya; S Oda; K Kurosu; N Tanabe; K Tatsumi; K Nagao; T Kuriyama
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.